NO125948B - - Google Patents

Download PDF

Info

Publication number: NO125948B
Authority: NO; Norway
Prior art keywords: calcium; amphomycin; water; aqueous; salt
Prior art date: 1970-01-21

Application number

NO20171A

Other languages

English (en)

Norwegian (no)

Inventor

H Kern

W Fischer

Original Assignee

Wieland Werke Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1970-01-21

Filing date

1971-01-20

Publication date

1972-11-27

1971-01-20 Application filed by Wieland Werke Ag filed Critical Wieland Werke Ag

1972-11-27 Publication of NO125948B publication Critical patent/NO125948B/no

Links

UVLNWXGLWVMUGD-AKDFLIFVSA-H [H+].[H+].CCC(CCCCC/C=C/CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H]([C@@H]2NC(=O)[C@@H]3N(C2=O)CCCC3)C)C(C)C)[C@@H](N)C)CC(=O)[O-])CC(=O)[O-])[C@H](C(=O)[O-])C)CC(=O)[O-])C.CCC(CCCCC/C=C/CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H]([C@@H]2NC(=O)[C@@H]3N(C2=O)CCCC3)C)C(C)C)[C@@H](N)C)CC(=O)[O-])CC(=O)[O-])[C@H](C(=O)[O-])C)CC(=O)[O-])C.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Ca+2].[Ca+2].[Ca+2] Chemical compound [H+].[H+].CCC(CCCCC/C=C/CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H]([C@@H]2NC(=O)[C@@H]3N(C2=O)CCCC3)C)C(C)C)[C@@H](N)C)CC(=O)[O-])CC(=O)[O-])[C@H](C(=O)[O-])C)CC(=O)[O-])C.CCC(CCCCC/C=C/CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(=O)N[C@H]([C@@H]2NC(=O)[C@@H]3N(C2=O)CCCC3)C)C(C)C)[C@@H](N)C)CC(=O)[O-])CC(=O)[O-])[C@H](C(=O)[O-])C)CC(=O)[O-])C.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Ca+2].[Ca+2].[Ca+2] UVLNWXGLWVMUGD-AKDFLIFVSA-H 0.000 claims description 24
239000002674 ointment Substances 0.000 claims description 17
238000002360 preparation method Methods 0.000 claims description 15
239000000243 solution Substances 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
238000000034 method Methods 0.000 claims description 11
159000000007 calcium salts Chemical class 0.000 claims description 10
239000004615 ingredient Substances 0.000 claims description 9
239000001110 calcium chloride Substances 0.000 claims description 7
229910001628 calcium chloride Inorganic materials 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 7
239000000725 suspension Substances 0.000 claims description 7
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
239000007900 aqueous suspension Substances 0.000 claims description 5
239000007864 aqueous solution Substances 0.000 claims description 4
-1 calcium chloride Chemical class 0.000 claims description 4
FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
239000001354 calcium citrate Substances 0.000 claims description 3
239000008223 sterile water Substances 0.000 claims description 3
235000013337 tricalcium citrate Nutrition 0.000 claims description 3
239000004227 calcium gluconate Substances 0.000 claims description 2
229960004494 calcium gluconate Drugs 0.000 claims description 2
235000013927 calcium gluconate Nutrition 0.000 claims description 2
NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
239000003883 ointment base Substances 0.000 claims description 2
230000000087 stabilizing effect Effects 0.000 claims description 2
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims 1
239000001527 calcium lactate Substances 0.000 claims 1
229960002401 calcium lactate Drugs 0.000 claims 1
235000011086 calcium lactate Nutrition 0.000 claims 1
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
239000000126 substance Substances 0.000 description 6
XBNDESPXQUOOBQ-LSMLZNGOSA-N (2r,3s)-4-[[(2s)-1-[[2-[[(2s)-1-[[2-[[(2r,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-[(3s,9ar)-1,4-dioxo-3,6,7,8,9,9a-hexahydro-2h-pyrido[1,2-a]pyrazin-3-yl]ethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-3-amino-1-oxobutan-2-yl]amino]-2-oxoethyl]am Chemical compound CCC(C)CCCCC\C=C\CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H]([C@H](C)N)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)[C@H]1C(=O)N2CCCC[C@@H]2C(=O)N1 XBNDESPXQUOOBQ-LSMLZNGOSA-N 0.000 description 4
108010079465 amphomycin Proteins 0.000 description 4
230000003115 biocidal effect Effects 0.000 description 4
239000000203 mixture Substances 0.000 description 4
235000021355 Stearic acid Nutrition 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
235000013772 propylene glycol Nutrition 0.000 description 3
238000003756 stirring Methods 0.000 description 3
FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
229930195708 Penicillin V Natural products 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
230000003796 beauty Effects 0.000 description 2
235000013871 bee wax Nutrition 0.000 description 2
239000012166 beeswax Substances 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000006071 cream Substances 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
229940056367 penicillin v Drugs 0.000 description 2
BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
239000000375 suspending agent Substances 0.000 description 2
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229920000569 Gum karaya Polymers 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
229920006197 POE laurate Polymers 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
241000934878 Sterculia Species 0.000 description 1
229930182558 Sterol Natural products 0.000 description 1
241000593950 Streptomyces canus Species 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
235000010407 ammonium alginate Nutrition 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
235000013877 carbamide Nutrition 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
150000001896 cresols Chemical class 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000003221 ear drop Substances 0.000 description 1
229940047652 ear drops Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
235000010494 karaya gum Nutrition 0.000 description 1
239000000231 karaya gum Substances 0.000 description 1
229940039371 karaya gum Drugs 0.000 description 1
150000002596 lactones Chemical class 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229910000000 metal hydroxide Inorganic materials 0.000 description 1
150000004692 metal hydroxides Chemical class 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000007923 nasal drop Substances 0.000 description 1
229940100662 nasal drops Drugs 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000021313 oleic acid Nutrition 0.000 description 1
150000002889 oleic acids Chemical class 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000002304 perfume Substances 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
239000012071 phase Substances 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 1
229960003733 phenylephrine hydrochloride Drugs 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
235000019422 polyvinyl alcohol Nutrition 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
235000010408 potassium alginate Nutrition 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
239000000770 propane-1,2-diol alginate Substances 0.000 description 1
DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000004289 sodium hydrogen sulphite Substances 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
XETSAYZRDCRPJY-UHFFFAOYSA-M sodium;4-aminobenzoate Chemical compound [Na+].NC1=CC=C(C([O-])=O)C=C1 XETSAYZRDCRPJY-UHFFFAOYSA-M 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
150000003432 sterols Chemical class 0.000 description 1
235000003702 sterols Nutrition 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
239000000606 toothpaste Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
229940099259 vaseline Drugs 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- E—FIXED CONSTRUCTIONS
- E06—DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
- E06B—FIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
- E06B3/00—Window sashes, door leaves, or like elements for closing wall or like openings; Layout of fixed or moving closures, e.g. windows in wall or like openings; Features of rigidly-mounted outer frames relating to the mounting of wing frames
- E06B3/32—Arrangements of wings characterised by the manner of movement; Arrangements of movable wings in openings; Features of wings or frames relating solely to the manner of movement of the wing
- E06B3/50—Arrangements of wings characterised by the manner of movement; Arrangements of movable wings in openings; Features of wings or frames relating solely to the manner of movement of the wing with more than one kind of movement
- E06B3/52—Wings requiring lifting before opening

Landscapes

Engineering & Computer Science (AREA)
Civil Engineering (AREA)
Structural Engineering (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
Hinges (AREA)
Wing Frames And Configurations (AREA)

NO20171A 1970-01-21 1971-01-20 NO125948B (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19707001919 DE7001919U (de)	1970-01-21	1970-01-21	Tuerfluegelrahmen.

Publications (1)

Publication Number	Publication Date
NO125948B true NO125948B (de)	1972-11-27

Family

ID=6608870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20171A NO125948B (de)	1970-01-21	1971-01-20

Country Status (10)

Country	Link
AT (1)	AT309774B (de)
BE (1)	BE761298A (de)
CH (1)	CH514770A (de)
DE (1)	DE7001919U (de)
DK (1)	DK133834B (de)
FR (1)	FR2077245B1 (de)
GB (1)	GB1292563A (de)
NL (1)	NL7100476A (de)
NO (1)	NO125948B (de)
SE (1)	SE358926B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK154938B (da) *	1976-04-17	1989-01-09	Talbot Waggonfab	Vaegdel til containere og koeretoejers vognkasser

1970
- 1970-01-21 DE DE19707001919 patent/DE7001919U/de not_active Expired
- 1970-12-07 AT AT1097670A patent/AT309774B/de active
1971
- 1971-01-07 FR FR7100345A patent/FR2077245B1/fr not_active Expired
- 1971-01-07 BE BE761298A patent/BE761298A/xx unknown
- 1971-01-08 CH CH27571A patent/CH514770A/de unknown
- 1971-01-13 NL NL7100476A patent/NL7100476A/xx unknown
- 1971-01-14 SE SE40571A patent/SE358926B/xx unknown
- 1971-01-14 GB GB190671A patent/GB1292563A/en not_active Expired
- 1971-01-20 NO NO20171A patent/NO125948B/no unknown
- 1971-01-21 DK DK26171A patent/DK133834B/da unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK154938B (da) *	1976-04-17	1989-01-09	Talbot Waggonfab	Vaegdel til containere og koeretoejers vognkasser

Also Published As

Publication number	Publication date
FR2077245A1 (de)	1971-10-22
DK133834C (de)	1977-01-24
SE358926B (de)	1973-08-13
FR2077245B1 (de)	1976-01-09
NL7100476A (de)	1971-07-23
CH514770A (de)	1971-10-31
GB1292563A (en)	1972-10-11
AT309774B (de)	1973-09-10
BE761298A (fr)	1971-07-07
DK133834B (da)	1976-07-26
DE7001919U (de)	1970-07-09

Publication	Publication Date	Title
Van Slyke et al.	1934	Relationships between urea excretion, renal blood flow, renal oxygen consumption, and diuresis. The mechanism of urea excretion
CA2090422C (en)	1996-02-13	Pharmaceutical composition of florfenicol
US5403858A (en)	1995-04-04	New compositions containing taxane derivatives
Harrop et al.	1935	Studies on the Suprarenal Cortex: IV. The Effect of Sodium Salts in Sustaining the Suprarenalectomized Dog
CA1050548A (en)	1979-03-13	Zinc sulfadiazine as a medicament
US4520014A (en)	1985-05-28	Treatment of diarrhoea
EP0735861A1 (de)	1996-10-09	Befeuchtende antimikrobielle zusammensetzungen
Ligou et al.	1960	Comparative effects of acidosis induced by acid infusion and CO2 accumulation
WESTFALL et al.	1968	The sensitivity of the guinea-pig pacemaker to norepinephrine and calcium after pretreatment with reserpine
TW201803561A (zh)	2018-02-01	軟性抗膽鹼類似物之製劑
EP2034956A1 (de)	2009-03-18	Zusammensetzungen mit glycosaminoglycanen niedriger viskosität und verwendung der zusammensetzung bei der behandlung von chronischer cystitis
CN1660130A (zh)	2005-08-31	含海藻糖和透明质酸的人体润滑剂及其制备方法
JPS61502821A (ja)	1986-12-04	薬物キットまたは薬物組成物
JPH11180821A (ja)	1999-07-06	硫酸化多糖類含有皮膚保湿乳剤性ローション剤
JPS60239421A (ja)	1985-11-28	創傷の肉芽および上皮形成を促進させるための局所性調合薬
KR20010031793A (ko)	2001-04-16	진통 처치용의 신규 제형
Clark et al.	1942	Intravenous Nourishment with Protein Carbohydrate and Fat in Man.
GB1282437A (en)	1972-07-19	Skin care composition and its preparation
HU196902B (en)	1989-02-28	Process for production of locally applicable medical compositions helping wound-granulation and formation of pellicle
WO2011025792A1 (en)	2011-03-03	Compositions for absorption and sustained action of leptin-related peptides
CN112704662B (zh)	2023-04-25	利多卡因乳膏、制备方法及其应用
JPH0214058B2 (de)	1990-04-06
CN103908463B (zh)	2016-06-15	一种林可霉素利多卡因凝胶剂及其制备工艺
US6617305B1 (en)	2003-09-09	Stable aqueous dispersion of nutrients
JPS62126130A (ja)	1987-06-08	動物用医薬組成物

NO125948B - - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=6608870

Family Applications (1)

Country Status (10)

Cited By (1)

Cited By (1)

Also Published As

Similar Documents